EBRD TO SELL STAKE IN RUSSIA’S NPO PETROVAX
December 5th, 2013
THE EUROPEAN Bank for Reconstruction & Development (EBRD) has announced that it will sell its stake in Russian vaccine producer NPO Petrovax. The bank had made a EUR15 million equity investment in the country in 2008, having lent it USD25 million in 2004 to finance developing a modern plant in Pokrov, near Moscow. This has been successful, with its scientists synthetising a new class of polymers which sparked the development of the immunomodulator Polyoxidonium. Now the company is seeking to sell control to Russia’s Interros, one of the country’s ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.